-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
January 01, 2023 - C
Sedation
3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21)
Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85)
Sedation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
January 01, 2022 - C
Sedation
3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21)
Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85)
Sedation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
October 01, 2016 - psychiatrically ill, violently
agitated patients requiring chemical restraint produced
more rapid sedation … and greater sedation overall than
intramuscular lorazepam68 (one RCT, insufficient SOE). … other medication
protocols:
Benefits
(continued)
Change in
aggressive
behavior
(continued)
Sedation … Another RCT reported on acute extrapyramidal
events and incidence of marked sedation in a comparison … flunitrazepam at 90 minutes.48
Marked sedation
28
Insufficient Medium risk of
bias, consistency
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Computer-assisted system (Sedasys) for propofol sedation during
gastrointestinal endoscopy procedures … Computer-assisted system (Sedasys) for propofol sedation during gastrointestinal
endoscopy procedures … system intended
to aid clinicians in delivering propofol for minimal to moderate sedation during routine … The Sedasys sedation system is
intended to allow teams led by physicians who are not anesthesiologists … expressed views that
the Sedasys system does not address a significant unmet need because alternative sedation
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/in-patients-with-dementia-what-is-the-effectiveness-of-psychological-treatment-ie-non-pharmacological-eg-cognitive-or-behavioral-therapy-for-individuals-with-dementia-environmental-and-behavioral-interventions-to-address-beh
November 01, 2017 - Weight gain, sedation, mortality associated with off-label use of atypical antipsychotics in dementia
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
February 15, 2017 - Other risks: akathisia, restlessness, sedation,
headache, nausea and vomiting
Olanzapine6 For bipolar … safety alert: DRESS (drug reaction
with eosinophilia and systemic symptoms)
FDA black box: delirium/sedation … syndrome with long acting injection (likely
not relevant to use in depression)
Other risks: akathisia, sedation … Quetiapine7 Yes, as an
adjunct with an
antidepressant
Other risks: sedation, hypertension,
cataracts … but not limited to
constipation, urinary retention and blurred vision) and CNS depression including
sedation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
December 01, 2010 - terms of extrapyramidal side effects and tardive dyskinesia, but produce other side
effects, including sedation … General: extrapyramidal side effects, weight gain, agitation, constipation,
sedation, elevated cholesterol … behaviors, death by suicide
General: extrapyramidal effects, weight
gain, agitation, constipation, sedation … • General adverse events: extrapyramidal effects, weight gain, agitation,
constipation, sedation,
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-repository-expanded-protocol.pdf
October 24, 2019 - Pharmacologic and Nonpharmacologic Treatments of Posttraumatic Stress Disorder
Evidence-based Practice Center Systematic Review Protocol
Project Title: Pharmacologic and Nonpharmacologic Treatments of Posttraumatic Stress
Disorder
I. Background and Objectives for the Systematic Review
Posttraumatic stress…
-
effectivehealthcare-admin.ahrq.gov/products/insomnia/clinician
March 01, 2021 - people with primary depression
Severe anaphylactic or anaphylactoid reactions
Possible profound sedation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
May 19, 2010 - that atypical antipsychotics can increase chances of adverse events such as significant weight
gain, sedation … Source: www.effectivehealthcare.ahrq.gov
Published Online: May 19, 2010
Tardive Dyskinesia
Sedation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
January 01, 2024 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/autism-adolescents_executive.pdf
August 01, 2012 - Harms
or adverse effects reported in studies of antipsychotic
medications included sedation, gastrointestinal … depression.21,40,44 Adverse effects described in the study
of naltrexone included nausea, fatigue, sedation … in studies of SRIs included fatigue, tremor,
tachycardia, agitation, gastrointestinal complaints,
sedation … As in the case of efficacy, the data on adverse
effects associated with risperidone, including sedation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plant-based-treatments-draft-report-2025-rct-table-app-e.xlsx
January 01, 2025 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_clinician.pdf
August 01, 2016 - immediate in nature:
�– Adverse events frequently reported with risperidone
included weight gain, sedation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/undescended-testicle_research-protocol.pdf
September 02, 2011 - Imaging approaches
include magnetic resonance angiography, which requires sedation or anesthesia and … Adverse effects, including but not limited to effects of sedation or anesthesia
Timing:
Timeframe
-
effectivehealthcare-admin.ahrq.gov/products/undescended-testicle/research-protocol
December 01, 2019 - Imaging approaches include magnetic resonance angiography, which requires sedation or anesthesia and … Need for further surgical intervention
Adverse effects, including but not limited to effects of sedation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_executive.pdf
August 01, 2012 - – General: extrapyramidal symptoms (EPS),
weight changes, agitation, constipation,
sedation, elevated … scores); positive, negative, and depressive
symptoms; relapse; quality of life; EPS; weight gain; and
sedation … Additionally, functional outcomes and symptomatic
outcomes (e.g., sedation, restlessness) were rarely
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
December 01, 2012 - resonance imaging (MRI), and
magnetic resonance (MR) angiography and venography,
some of which require sedation … Both techniques require
anesthesia or sedation. … Some approaches require sedation, and reported
success rates may reflect, in part, differences in the
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
June 04, 2010 - Side effects vary among the various medications, but
common side effects include dry mouth, sedation … • Weight gain (e.g., using Body Mass Index (BMI) growth charts)
• Agitation
• Constipation
• Sedation … events: extrapyramidal effects, weight gain (e.g., using BMI growth
charts), agitation, constipation, sedation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2024-surv-rep-update-table-appendix-e.xlsx
January 01, 2024 - C
Sedation
3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21)
Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85)
Sedation